Drugmaker Parabilis Raises $745 Million in US IPO, Placement
Original Report
Parabilis Medicines Inc., a clinical-stage cancer drug developer, raised nearly $745 million in an upsized US initial public offering that priced above its marketed range, and a private placement.
Glass House Analysis
Inflation is the silent tax that erodes purchasing power, hitting hardest those who can least afford it. When grocery bills rise faster than wages, families face impossible choices between food, medicine, and rent. Unlike market volatility that mainly affects investors, inflation touches everyone who buys groceries, fills a gas tank, or pays rent.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
India Bank Shares Jump as Deposit, Yield Worries Ease
Large private banks are trading near their cheapest levels in a decade.
Oracle’s stock has surged on AI hype. Now it has to deliver the earnings to match.
Oracle’s fourth-quarter earnings call will deliver critical updates about the progress of its data-center build-out and the financial impact of its AI pivot.
China factory gate prices rise at fastest rate in 4 years
Energy costs climb as Iran war cuts off supply through Strait of Hormuz
Hong Kong Will Inspire China’s Confidence on Capital Flows, Says City’s Financial Secretary
Hong Kong Financial Secretary Paul Chan said the city would attempt to “inspire the confidence” of Chinese authorities, after Beijing’s sweeping crackdown on illicit overseas investment cast a chill...